Why IMU is a multi multi bagger, page-12902

hi @fraedu

as a really quick response:

The last Her-Vaxx update was the announcement in September last year, announcing the first patient dosed in the Combo trial (nextHerizon) of Her-Vaxx with Pembrolizumab; Subequent announcements from Imugene that were Her-Vaxx releated, were announcements outlining the presentation of Her-Vaxx data at both ESMO and ASCO conferences. Check the Imugene website here for the poster presentations:

Conference Presentations — Imugene (ASX: IMU)

Prior to the 1st patient dosed announcement for the Her-Vaxx combo trial, OS data from the original Her-Vaxx Phase 2 trial was announced in July 2022.

We are now waiting for Imugene to make announcements on:

1. Her-Vaxx neoHorizon trial
2. Interim readouts on the nextHerizon trial (Her-Vaxx in combo with Pembro).

Hope this helps.

GLTAH.